Tsanangudzo Yakadzama
Tadalafil ichena kusvika kune-white crystalline powder.Inoita isinganyunguriki mumvura, ichiratidza kunyungudika zvishoma, uye inonyungudika zvishoma mudoro.
Tadalafil's primary basa ndere kurapa erectile dysfunction nekuwedzera kuyerera kweropa kupenisi panguva yekukurudzira pabonde.Inozadzisa izvi nekuvharira enzyme phosphodiesterase type 5(PDE5), iyo inokonzera kuderedzwa kwe cyclic guanosine monophosphate(cGMP) mu corpus cavernosum. Nekudzivisa PDE5, tadalafil inobvumira kwenguva yakareba vasodilation uye kuwedzerwa kweropa, iyo inobatsira varume vane erectile dysfunction kuti vawane uye vatsigire erection.Kusiyana nemamwe mishonga yeED, tadalafil ine nguva yakareba yekuita, nemigumisiro inowanzogara kwenguva refu. kusvika kumaawa makumi matatu nematanhatu, uchiwana zita remadunhurirwa rekuti "piritsi revhiki."
Tadalafil inonyanya kuratidzirwa kurapwa kwe erectile dysfunction (ED) muvarume vakuru. Inowanikwa mufomu yepiritsi yekushandiswa kwemuromo, mumatareji kubva ku2.5 mg kusvika ku20 mg, zvichienderana nezvinodiwa nemurwere uye mamiriro ari kurapwa. Iyo yakakurudzirwa yekutanga dose yevarwere vazhinji ndeye 10 mg, inotorwa isati yatarisirwa kuita zvepabonde, uye kana pasina chikafu. Chiyero chinogona kugadziriswa zvichienderana nekushivirira kwega uye mhinduro.Kuwedzera pakushandiswa kwayo kwe erectile dysfunction, tadalafil inobvumirwawo kurapwa kwezviratidzo uye zviratidzo zvebenign prostatic hyperplasia (BPH), chirwere chinoratidzwa neprostate gland yakakura. Kana BPH ichiperekedzwa ne erectile dysfunction, tadalafil inogona kupa mbiri mbiri nekugadzirisa zvese zviri zviviri panguva imwe chete.
Uyezve, tadalafil inoshandiswa kubata pulmonary arterial hypertension (PAH) mune vese varume nevakadzi. Muchishandiso ichi, zvinobatsira kuvandudza kugona kwekurovedza muviri uye kunonoka kuwedzera kwekiriniki kwechirwere.
Mukupedzisa, tadalafil ichena kusvika kune-chena crystalline poda ine mashoma solubility, inonyanya kushandiswa kurapa erectile dysfunction, benign prostatic hyperplasia, uye pulmonary arterial hypertension. SePDE5 inhibitor, inofambisa kuwedzerwa kweropa kune dzimwe nzvimbo dzemuviri, kunyanya peni, iyo inogonesa kuvandudzwa kwe erectile basa. Pamusoro pezvo, kureba kwayo kwechiito kunoiisa parutivi kubva kune mimwe mishonga mukirasi yayo, ichipa kuchinjika uye kuzvimiririra kune vanhu vari kutsvaga kurapwa kweED.
Tsanangudzo
